Paul E. Fagerness

1.3k total citations
34 papers, 1.1k citations indexed

About

Paul E. Fagerness is a scholar working on Molecular Biology, Materials Chemistry and Spectroscopy. According to data from OpenAlex, Paul E. Fagerness has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Materials Chemistry and 9 papers in Spectroscopy. Recurrent topics in Paul E. Fagerness's work include Porphyrin Metabolism and Disorders (10 papers), Porphyrin and Phthalocyanine Chemistry (10 papers) and Advanced NMR Techniques and Applications (7 papers). Paul E. Fagerness is often cited by papers focused on Porphyrin Metabolism and Disorders (10 papers), Porphyrin and Phthalocyanine Chemistry (10 papers) and Advanced NMR Techniques and Applications (7 papers). Paul E. Fagerness collaborates with scholars based in United States, Germany and Italy. Paul E. Fagerness's co-authors include Michael Barfield, Ping Gao, Claudio Dalvit, Brian J. Stockman, Ronald W. Sarver, A. Ian Scott, Gerardo Burton, M J Hauer, Neil E. Mackenzie and David M. Grant and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Chemical Physics.

In The Last Decade

Paul E. Fagerness

32 papers receiving 982 citations

Peers

Countries citing papers authored by Paul E. Fagerness

Since Specialization

Citations

This map shows the geographic impact of Paul E. Fagerness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Fagerness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Fagerness more than expected).

Fields of papers citing papers by Paul E. Fagerness

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Fagerness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Fagerness. The network helps show where Paul E. Fagerness may publish in the future.

Co-authorship network of co-authors of Paul E. Fagerness

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Fagerness. A scholar is included among the top collaborators of Paul E. Fagerness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Fagerness. Paul E. Fagerness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of bropirimineO-glucuronidation in human liver microsomes 2003 ·Xenobiotica ·Michael A. Wynalda, (unknown), Benny Amore, Paul E. Fagerness, Larry C. Wienkers	9
2	Fluorine-NMR Experiments for High-Throughput Screening: Theoretical Aspects, Practical Considerations, and Range of Applicability 2003 ·Journal of the American Chemical Society ·Claudio Dalvit, Paul E. Fagerness, (unknown), Ronald W. Sarver, Brian J. Stockman	190
3	Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats. 1997 ·PubMed ·Mayland Chang, (unknown), (unknown), (unknown), P E Sanders, M J Hauer, Paul E. Fagerness	12
4	Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys. 1997 ·PubMed ·Mayland Chang, (unknown), (unknown), M J Hauer, Paul E. Fagerness, P E Sanders, (unknown)	11
5	Spectroscopic studies of delavirdine mesylate (U‐90,152T) a bis(heteroaryl)piperazine (BHAP) HIV reverse transcriptase inhibitor 1996 ·Journal of Heterocyclic Chemistry ·Kathleen A. Farley, Gregory S. Walker, Russell H. Robins, (unknown), (unknown), Donna L. Romero, (unknown), P. A. MEULMAN, (unknown), Jeffrey L. Havens, James R. Gage, Mark A. Lyster, Paul E. Fagerness, Gary E. Martin	2
6	Diffusion in HPMC Gels. I. Determination of Drug and Water Diffusivity by Pulsed-Field-Gradient Spin-Echo NMR 1995 ·Pharmaceutical Research ·Ping Gao, Paul E. Fagerness	93
7	The 3′-Keto–Diol Equilibrium of Trospectomycin Sulfate Bulk Drug and Freeze-Dried Formulation: Solid-State Carbon-13 Cross-Polarization Magic Angle Spinning (CP/MAS) and High-Resolution Carbon-13 Nuclear Magnetic Resonance (NMR) Spectroscopy Studies 1993 ·Pharmaceutical Research ·Michael D. Likar, Richard J. Taylor, Paul E. Fagerness, Yukio Hiyama, Russell H. Robins	8
8	Identification of degradation products occurring in acidic solutions of a 21-aminosteroid (tirilazad) 1990 ·International Journal of Pharmaceutics ·(unknown), (unknown), Paul E. Fagerness, Russell H. Robins, (unknown)	1
9	Preferred conformational state of the N‐terminus section of a bovine growth hormone fragment (residues 96‐133) in water is an omega loop 1988 ·Proteins Structure Function and Bioinformatics ·Paul R. Gooley, (unknown), Paul E. Fagerness, Neil E. Mackenzie	3
10	¹H, ³H and ¹³C NMR studies on porphobilinogen 1985 ·Magnetic Resonance in Chemistry ·Jeremy N. S. Evans, Paul E. Fagerness, Neil E. Mackenzie, A. Ian Scott	12
11	Control of porphyrin biosynthesis in Rhodopseudomonas spheroides and Propionibacterium shermanii. A direct 13C nuclear-magnetic-resonance spectroscopy study 1981 ·Biochemical Journal ·Gerardo Burton, Peter M. Jordan, Neil E. Mackenzie, Paul E. Fagerness, A. Ian Scott	4
12	Oxidation reactions by prostaglandin cyclooxygenase-hydroperoxidase. 1981 ·Journal of Biological Chemistry ·Robert W. Egan, Paul H. Gale, (unknown), (unknown), W.J.A. Vandenheuvel, Robert Walker, Paul E. Fagerness, F. A. Kuehl	92
13	N.m.r. spectroscopy as a probe for the study of enzyme-catalysed reactions. Further observations of preuroporphyrinogen, a substrate for uroporphyrinogen III cosynthetase 1980 ·Journal of the Chemical Society Chemical Communications ·A. Ian Scott, Gerardo Burton, Peter M. Jordan, Hiroo Matsumoto, Paul E. Fagerness, (unknown)	9
14	The use of carbon-13 magnetic resonance chemical shifts and long-range¹³C–¹H coupling constants for assigning the site of glycosylation on nitrogen heterocycles 1980 ·Journal of the Chemical Society Perkin Transactions 2 ·(unknown), Paul E. Fagerness, Raymond P. Panzica, Leroy B. Townsend	11
15	The carbon-13 and nitrogen-15 nuclear magnetic resonance spectra of uroporphyrinogens I and III 1980 ·Tetrahedron ·Gerardo Burton, Paul E. Fagerness, Peter M. Jordan, A. Ian Scott	1
16	Direct non-invasive observation of metabolism in living cells by ¹³C nuclear magnetic resonance spectroscopy 1980 ·Canadian Journal of Chemistry ·Gerardo Burton, Robert L. Baxter, (unknown), Philip J. Sidebottom, Paul E. Fagerness, Kozo Shishido, John Y. Lee, Anna I. Scott	11
17	Structure of preuroporphyrinogen. Exploration of an enzyme mechanism by carbon-13 and nitrogen-15 NMR spectroscopy 1979 ·Journal of the American Chemical Society ·Gerardo Burton, (unknown), (unknown), Hideki Matsumoto, Peter M. Jordan, Paul E. Fagerness, (unknown), A. Ian Scott	16
18	Direct observation of porphyrinogen biosynthesis in living cells by 13C n.m.r. spectroscopy 1979 ·Journal of the Chemical Society Chemical Communications ·A. Ian Scott, Gerardo Burton, Paul E. Fagerness	5
19	13C n.m.r. evidence for a new intermediate, pre-uroporphyrinogen, in the enzymic transformation of porphobilinogen into uroporphyrinogens I and III 1979 ·Journal of the Chemical Society Chemical Communications ·Gerardo Burton, Paul E. Fagerness, (unknown), Peter M. Jordan, A. Ian Scott	49
20	Spin–lattice relaxation in coupled three spin systems of the A I S type 1975 ·The Journal of Chemical Physics ·Paul E. Fagerness, David M. Grant, Karl Kuhlmann, Charles L. Mayne, (unknown)	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact